| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.064 | 0.2 |